Harvard Bioscience, Inc. provided earnings guidance for full year 2023. For the year, the company expects revenues of approximately $116 million to $120 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.62 USD | +1.69% | -2.16% | -32.34% |
Apr. 09 | Harvard Bioscience Reducing Headcount | MT |
Apr. 09 | Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.34% | 157M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- HBIO Stock
- News Harvard Bioscience, Inc.
- Harvard Bioscience, Inc. Provides Earnings Guidance for Full Year 2023